Obalon Therapeutics

From Verify.Wiki
Jump to: navigation, search
Obal.png
http://www.obalon.com/
Obalon Therapeutics, Inc.
Type Public
Industry Healthcare
Founded 2008[1]
Headquarters Carlsbad, California
Key people Andrew P. Rasdal(CEO), William J. Plovanic(CFO), Mark Brister(VP)[2]
Investors AMOREPACIFIC Ventures, Axon Ventures, Bader Sultan & Bros, Domain Associates, InterWest Partners, Mirae Asset Venture Investment, Neoplux, Okapi Venture Capital, Square 1 Bank, Striker Asia Opportunities Fund[3][4][5][6][7][8][9]
Number of employees 100+

Obalon Therapeutics, Inc. is a commercial-stage medical device company, they focus on developing and commercializing medical devices to treat obese and overweight people by facilitating weight loss. It offers the Obalon balloon system designed to provide weight loss in obese patients. The company provides its products through distributors. Obalon Therapeutics, Inc. was founded in 2008 and is headquartered in Carlsbad, California.

History

  • July 18, 2012, Obalon® secures $16.5 Million Series C financing and achieves key milestones in providing a novel, nonsurgical device for weight loss.[10]
  • January 24, 2015, Obalon gets $30M to complete pivotal trial in 2015, EnteroMedics gains FDA approval.[11]
  • September 9, 2016, Obalon Therapeutics files to go public.[12]
  • September 12, 2016, Obalon announced FDA Approval of Obalon Balloon System.[13]
  • October 5, 2016, Obalon Therapeutics, Inc. announced the pricing of its initial public offering of 5,000,000 shares of its common stock at a price to the public of $15.00 per share.[14]

Controversies

Top 5 Recent Tweets

DateAuthorComment
June 01, 2021PatentGrants$OBLN Obalon Therapeutics has received a decision to grant European patent number EP3077037 titled "SYSTEM FOR LOCA… https://t.co/4ReRwujulw


Top 5 Recent News Headlines

Top 5 Lifetime Tweets

Top 5 Lifetime News Headlines

  1. https://www.linkedin.com/company/obalon-therapeutics
  2. http://www.obalon.com/obalon-corporate/
  3. https://www.crunchbase.com/funding-round/ed2223b9259ff0921783ed7f2743b713
  4. https://www.crunchbase.com/funding-round/5addae3ea1f81bbdd544f8b09b74a759
  5. https://www.crunchbase.com/funding-round/a59e0cbd9e26f45f20ea4bb7e6c1f00f
  6. https://www.crunchbase.com/funding-round/75b58e7dd1add2c291325a4fedc71ce9
  7. https://www.crunchbase.com/funding-round/690c3b7fe74cec08797381e44db94d39
  8. https://www.crunchbase.com/funding-round/2c2a293c6bdaa4f867b4f645bceb5f51
  9. https://www.crunchbase.com/funding-round/ed2223b9259ff0921783ed7f2743b713
  10. http://www.businesswire.com/news/home/20120718006633/en/Obalon%C2%AE-Secures-16.5-Million-Series-Financing-Achieves
  11. http://www.fiercebiotech.com/medical-devices/obesity-devices-aim-for-u-s-as-obalon-gets-30m-to-complete-pivotal-trial-2015
  12. http://www.sandiegouniontribune.com/business/biotech/sdut-obalon-carlsbad-ipo-2016sep09-story.html
  13. http://www.obalon.com/obalon-announces-fda-approval-of-obalon-balloon-system/
  14. https://globenewswire.com/news-release/2016/10/05/877421/0/en/Obalon-Therapeutics-Announces-Pricing-of-Initial-Public-Offering.html

Verification history